Drs. David McDermott and Brian Rini debate treatment options (PD1/VEGF versus PD1/CTLA4) in front-line renal cancer. It’s hard to identify any winners from this podcast.
The Uromigos Episode 67: The Third Debate—PD1/VEGF Versus PD1/CTLA4 for Front-Line Renal Cancer
By The Uromigos - Last Updated: November 17, 2020
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.